Baird lowered the firm’s price target on Global Medical REIT (GMRE) to $41 from $45 and keeps a Neutral rating on the shares. The firm updated its model following Q3 results which suggest the tough capital markets may lead to asset recycling.
Claim 70% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on GMRE:
- Global Medical REIT Reports Q3 2025 Financial Results
- Global Medical REIT Inc’s Earnings Call Highlights Balanced Outlook
- Global Medical REIT reports Q3 FFO $1.00, consensus $1.05
- Global Medical REIT sees FY25 AFFO $4.50-$4.60 vs. previous $4.45-$4.65
- Global Medical REIT Inc (GMRE) Q3 Earnings Cheat Sheet